Document Type : Original Research Article
Authors
- Zohreh AkhoundiMeybodi 1
- Maryam Dehghan 2
- Seyed Alireza Mousavi 3
- Mahmood Vakili 4
- Noor Foroghi nasab 5
- Seyed Hossein shahcheraghi 3
- Mahdie Hamidfar 3
- Faezehsadat Heidari 3
- bijan jafarnia 1
- kazem ansari 6
1 Infectious Diseases Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3 Infectious Diseases Research Center, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 Department of Community Medicine, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
5 Shahid Sadoughi University of Medical Sciences, Yazd, Iran
6 MD, Nano-Biotech Foresight Company Biotechnology Campus, Yazd Stem Cells and Regenerative Medicine Institute, Yazd, Iran
Abstract
Covid-19 patients have coagulation complications resulting in poor prognosis. Therefore, this study aimed to investigate the prevalence of coagulation disorders in patients with Covid-19 admitted to Shahid Sadoughi Hospital in Yazd. This study was a cross-sectional study that all patients admitted with a diagnosis of Covid-19 from the beginning of February 2020 to the end of April 2020 were examined for the frequency of coagulation dysfunctions. A total of 441 patients with Covid-19 were included in the study with a mean age of 55.4 years that 47.8 %, 25.6 % and 6.8 % had impaired Prothrombin Time (PT), Partial Thromboplastin Time (PTT) and International Normalized Ratio (INR), respectively.
Keywords
Main Subjects